Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_imr90r1_promoter_n_PM_16_21_17			2	1.0	1.67E-05	DPM3, TAS1R2	dolichol-phosphate-mannose synthase complex [CC], sweet taste receptor activity [MF], detection of chemical stimulus involved in sensory perception of sweet taste [BP], protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP], mannosyltransferase complex [CC], dolichyl-phosphate beta-D-mannosyltransferase activity [MF]
CG_imr90r1_promoter_n_PM_12_115_4			1	0.5	4.14E-05	HAL, CDK5, FGF8, ODC1, BAZ1B	putrescine biosynthetic process from ornithine [BP], cell migration involved in mesendoderm migration [BP], vitamin D receptor activator activity [MF], ornithine decarboxylase activity [MF], cerebellar cortex formation [BP], histidine ammonia-lyase activity [MF], DNA replication-dependent nucleosome disassembly [BP], acetylcholine receptor activator activity [MF]
CG_imr90r1_promoter_n_PM_12_113_10			2	1.0	6.91E-05	MCCC1, IL18	biotin metabolic process [BP], positive regulation of male germ cell proliferation [BP], methylcrotonoyl-CoA carboxylase activity [MF], interleukin-13 biosynthetic process [BP], positive regulation of blood vessel remodeling [BP], positive regulation of NK T cell proliferation [BP]
CG_imr90r1_promoter_n_PM_18_21_11			2	1.0	1.65E-05	GPLD1, LRP6, SCIMP, CD74	tetraspanin-enriched microdomain [CC], uropod membrane [CC], NOS2-CD74 complex [CC], cellular response to cholesterol [BP], receptor complex [CC], macrophage migration inhibitory factor receptor complex [CC]
CG_imr90r1_promoter_n_PM_14_25_8			2	1.0	4.00E-05	LCT	lactase activity [MF], glycosylceramidase activity [MF]
CG_imr90r1_promoter_n_PM_18_11_12			2	1.0	1.96E-05	SEPT12	sperm annulus [CC]
CG_imr90r1_promoter_n_PM_14_17_11			2	1.0	1.69E-05	AGA	protein deglycosylation [BP], N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [MF]
CG_imr90r1_promoter_n_PM_12_11_7			1	0.5	6.15E-05	AGXT2, CDO1	taurine biosynthetic process [BP], cysteine dioxygenase activity [MF], glycine biosynthetic process, by transamination of glyoxylate [BP], L-alanine catabolic process, by transamination [BP], beta-alanine-pyruvate transaminase activity [MF], (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [MF]
CG_imr90r1_promoter_n_PM_12_94_11			1	0.5	2.56E-04	UMOD	metanephric thick ascending limb development [BP], metanephric ascending thin limb development [BP]
CG_imr90r1_promoter_n_PM_12_74_6			1	0.5	1.34E-05	PDLIM7, PPP1R9B	cellular response to morphine [BP], ruffle [CC], regulation of opioid receptor signaling pathway [BP]
CG_imr90r1_promoter_n_PM_12_48_6			1	0.5	9.11E-05	FRZB	negative regulation of hepatocyte differentiation [BP]
CG_imr90r1_promoter_n_PM_14_48_7			1	0.5	5.62E-05	RFC4, SMARCC1, CHD4, SIN3A, SUPT16H	DNA replication [BP], RNA polymerase II repressing transcription factor binding [MF], nucleosome disassembly [BP]
CG_imr90r1_promoter_n_PM_12_128_5			2	1.0	6.92E-05	HEY1, TRPV4	vasopressin secretion [BP], arterial endothelial cell differentiation [BP], atrioventricular valve formation [BP], cortical microtubule organization [BP], microsatellite binding [MF], umbilical cord morphogenesis [BP], osmosensory signaling pathway [BP], negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [BP], positive regulation of microtubule depolymerization [BP], osmosensor activity [MF]
CG_imr90r1_promoter_n_PM_20_4_23			2	1.0	4.29E-05	DPF1, SMARCC1	nBAF complex [CC]
CG_imr90r1_promoter_n_PM_12_59_3			1	0.5	6.74E-05	BHLHE23	negative regulation of retinal cell programmed cell death [BP]
CG_imr90r1_promoter_n_PM_12_154_7			2	1.0	9.87E-05	COL4A3BP, ATP8B1, GNA12, NUDT12	NAD catabolic process [BP], brush border membrane [CC], ceramide transporter activity [MF], NAD+ diphosphatase activity [MF]
CG_imr90r1_promoter_n_PM_12_18_8			1	0.5	7.50E-05	MTOR, OXER1	5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], regulation of carbohydrate utilization [BP], 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], mTOR-FKBP12-rapamycin complex [CC], 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF]
CG_imr90r1_promoter_n_PM_14_21_9			3	1.0	1.52E-05	RFC1, COQ3, SEC31A, AP1S3, DDOST	protein N-linked glycosylation via asparagine [BP], membrane coat [CC], protein N-linked glycosylation [BP], DNA clamp loader activity [MF], 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF], antigen processing and presentation of exogenous peptide antigen via MHC class II [BP], 3-demethylubiquinone-9 3-O-methyltransferase activity [MF], hexaprenyldihydroxybenzoate methyltransferase activity [MF]
CG_imr90r1_promoter_n_PM_16_26_8			1	0.5	3.36E-05	ENTPD5	guanosine-diphosphatase activity [MF]
CG_imr90r1_promoter_n_PM_12_69_5			2	1.0	4.66E-05	FBXO5	spindle assembly involved in female meiosis I [BP], inhibition of mitotic anaphase-promoting complex activity [BP]
CG_imr90r1_promoter_n_PM_16_13_6			2	1.0	4.81E-05	CDK5RAP2	negative regulation of centriole replication [BP]
CG_imr90r1_promoter_n_PM_12_44_5			2	1.0	7.66E-05	GLMN, AKR1B1, RARS2, CARS2	hepatocyte growth factor receptor binding [MF], glyceraldehyde oxidoreductase activity [MF], tRNA aminoacylation for protein translation [BP]
CG_imr90r1_promoter_n_PM_12_142_12			1	0.5	2.47E-04	CASP5, MYH6, MYH15, CASP1, CARD17	myosin filament [CC], cysteine-type endopeptidase activity [MF], NLRP1 inflammasome complex [CC], cysteine-type peptidase activity [MF]
CG_imr90r1_promoter_n_PM_20_1_77			2	1.0	4.38E-05	UCN, KIAA0101, BAZ1B, MTOR, PCNA	negative regulation of cell size [BP], regulation of glycogen biosynthetic process [BP], nuclear replication fork [CC], translesion synthesis [BP]
CG_imr90r1_promoter_n_PM_18_19_14			2	1.0	5.59E-05	VPS54, HMGB1	neuron projection [CC], musculoskeletal movement [BP]
CG_imr90r1_promoter_n_PM_12_29_4			1	0.5	8.67E-05	JUN, FLCN	leading edge cell differentiation [BP], cellular response to potassium ion starvation [BP], negative regulation of energy homeostasis [BP]
CG_imr90r1_promoter_n_PM_12_126_5			1	0.5	2.95E-05	CLCF1	positive regulation of isotype switching to IgE isotypes [BP], CNTFR-CLCF1 complex [CC], CRLF-CLCF1 complex [CC]
CG_imr90r1_promoter_n_PM_12_150_5			2	1.0	1.66E-05	DPM3	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [BP], dolichol-phosphate-mannose synthase complex [CC], mannosyltransferase complex [CC]
CG_imr90r1_promoter_n_PM_20_14_25			2	1.0	4.67E-05	DHX16, DDX39A, SIRT2	chromatin silencing at telomere [BP], tubulin deacetylase activity [MF], ATP-dependent helicase activity [MF]
CG_imr90r1_promoter_n_PM_14_27_6			2	1.0	6.41E-05	PHOX2B, MSRB1, CYP2D6, BAZ2A	heterochromatin assembly involved in chromatin silencing [BP], methionine-R-sulfoxide reductase activity [MF], retrotrapezoid nucleus neuron differentiation [BP], medullary reticular formation development [BP], negative regulation of cellular organofluorine metabolic process [BP], neural crest cell migration involved in autonomic nervous system development [BP], efferent axon development in a lateral line nerve [BP]
CG_imr90r1_promoter_n_PM_12_4_5			1	0.5	4.06E-05	MDC1, MB21D1, MTHFR	cyclic-GMP-AMP synthase activity [MF], FHA domain binding [MF], methylenetetrahydrofolate reductase (NADPH) activity [MF]
CG_imr90r1_promoter_n_PM_12_139_8			1	0.5	3.29E-05	HNRPDL	poly(G) RNA binding [MF]
CG_imr90r1_promoter_n_PM_16_24_5			2	1.0	2.37E-05	LBX1, DHPS, OXER1	5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], deoxyhypusine biosynthetic process from spermidine [BP], regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP], 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [MF], deoxyhypusine synthase activity [MF]
CG_imr90r1_promoter_n_PM_12_140_5			1	0.5	1.99E-04	AK2	sperm mitochondrial sheath [CC]
CG_imr90r1_promoter_n_PM_12_62_5			1	0.5	2.05E-05	GMPPB	mannose-1-phosphate guanylyltransferase activity [MF]
CG_imr90r1_promoter_n_PM_14_33_7			2	1.0	7.17E-06	MYL2	muscle cell fate specification [BP]
CG_imr90r1_promoter_n_PM_12_63_9			1	0.5	9.08E-05	DPH5	peptidyl-diphthamide biosynthetic process from peptidyl-histidine [BP], diphthine synthase activity [MF]
CG_imr90r1_promoter_n_PM_16_19_10			2	1.0	8.86E-05	VPS41	Golgi vesicle transport [BP]
CG_imr90r1_promoter_n_PM_14_3_7			2	1.0	4.87E-05	ARFGAP3, ADAP1	regulation of GTPase activity [BP], regulation of ARF GTPase activity [BP], ARF GTPase activator activity [MF]
CG_imr90r1_promoter_n_PM_14_45_7			2	1.0	3.81E-05	NUFIP2, NR0B1	polysomal ribosome [CC]
CG_imr90r1_promoter_n_PM_14_47_7			2	1.0	3.64E-05	SLC22A17	siderophore transport [BP]
CG_imr90r1_promoter_n_PM_12_56_4			1	0.5	1.61E-04	CSDA, SEC23A, SERBP1, HLA-DPA1	regulation of mRNA stability [BP], ER to Golgi transport vesicle membrane [CC], positive regulation of cytoplasmic translation [BP], mRNA 3'-UTR binding [MF]
CG_imr90r1_promoter_n_PM_20_10_15			2	1.0	4.57E-05	KAT2A	histone deubiquitination [BP]
CG_imr90r1_promoter_n_PM_12_98_9			2	1.0	3.41E-05	RBBP7, MOGS	mannosyl-oligosaccharide glucosidase activity [MF], cellular heat acclimation [BP]
CG_imr90r1_promoter_n_PM_12_67_4			1	0.5	1.11E-04	MBOAT4	serine O-acyltransferase activity [MF]
CG_imr90r1_promoter_n_PM_12_152_5			2	1.0	3.09E-05	TOLLIP	interleukin-18 receptor complex [CC]
CG_imr90r1_promoter_n_PM_14_23_17			2	1.0	3.91E-05	SRSF12, STAR, SEC63, NDUFAF1	unfolded protein binding [MF], cellular response to luteinizing hormone stimulus [BP]
CG_imr90r1_promoter_n_PM_12_109_4			2	0.5	1.01E-04	LRP8, BAAT, LIG1, SEMA4D	bile acid conjugation [BP], ammon gyrus development [BP], regulation of dendrite morphogenesis [BP], telomere maintenance via semi-conservative replication [BP]
CG_imr90r1_promoter_n_PM_12_79_4			1	0.5	1.74E-05	RAD54B, LIPE	DNA translocase activity [MF], hormone-sensitive lipase activity [MF]
CG_imr90r1_promoter_n_PM_12_50_4			1	0.5	3.87E-05	ALG8, HSPD1	alpha-1,3-mannosyltransferase activity [MF], positive regulation of T cell mediated immune response to tumor cell [BP], B cell cytokine production [BP]
CG_imr90r1_promoter_n_PM_12_132_12			1	0.5	2.27E-04	CDK5	acetylcholine receptor activator activity [MF]
CG_imr90r1_promoter_n_PM_12_84_6			1	0.5	3.62E-05	CD79B, BCDIN3D	B cell receptor complex [CC], negative regulation of pre-miRNA processing [BP]
CG_imr90r1_promoter_n_PM_18_17_12			2	1.0	6.91E-05	BAD, OAT, EXOSC10	nuclear retention of unspliced pre-mRNA at the site of transcription [BP], cellular nitrogen compound metabolic process [BP], cellular response to chromate [BP]
CG_imr90r1_promoter_n_PM_12_52_7			2	0.5	5.01E-05	POFUT2	peptide-O-fucosyltransferase activity [MF], protein O-linked fucosylation [BP]
CG_imr90r1_promoter_n_PM_18_18_26			2	1.0	1.84E-05	TNFRSF10A, IRF7, MEFV, HSPD1	interferon-alpha production [BP], positive regulation of interferon-alpha production [BP], activation of cysteine-type endopeptidase activity involved in apoptotic process [BP], positive regulation of cysteine-type endopeptidase activity [BP]
CG_imr90r1_promoter_n_PM_12_89_5			1	0.5	1.43E-05	OMG, ALDH18A1	regulation of collateral sprouting of intact axon in response to injury [BP], glutamate 5-kinase activity [MF], glutamate-5-semialdehyde dehydrogenase activity [MF], ornithine biosynthetic process [BP]
CG_imr90r1_promoter_n_PM_20_11_20			1	0.5	4.14E-05	LSM7	U6 snRNA binding [MF]
CG_imr90r1_promoter_n_PM_14_40_11			1	0.5	2.51E-05	DENND2A	actin cortical patch [CC]
CG_imr90r1_promoter_n_PM_12_58_4			1	0.5	6.54E-05	TJP1, TLR1, RAB23, PDF	phagocytic vesicle [CC], phagocytic vesicle membrane [CC], peptide deformylase activity [MF], cell-cell signaling involved in cell-cell junction organization [BP]
CG_imr90r1_promoter_n_PM_14_26_10			2	1.0	9.25E-05	OAZ2, OTUD7B	protein K11-linked deubiquitination [BP], ornithine decarboxylase inhibitor activity [MF]
CG_imr90r1_promoter_n_PM_12_155_5			2	1.0	5.06E-05	MB, PLA2G1B	multicellular organismal lipid catabolic process [BP], slow-twitch skeletal muscle fiber contraction [BP]
CG_imr90r1_promoter_n_PM_18_5_8			2	1.0	7.36E-05	MLH3, PARP10, PARP16	mismatched DNA binding [MF], NAD+ ADP-ribosyltransferase activity [MF]
CG_imr90r1_promoter_n_PM_14_55_7			2	1.0	4.19E-05	PCOLCE2	peptidase activator activity [MF]
CG_imr90r1_promoter_n_PM_18_15_22			2	1.0	5.67E-05	YBX2, GDNF	mRNA stabilization [BP]
CG_imr90r1_promoter_n_PM_12_9_7			2	1.0	1.07E-04	EIF2AK2, TGFBR3	evasion or tolerance by virus of host immune response [BP], transforming growth factor beta receptor activity, type III [MF]
CG_imr90r1_promoter_n_PM_12_49_9			2	1.0	1.08E-04	NLRP10, COL12A1, CBS	collagen type XII [CC], homocysteine catabolic process [BP], helper T cell enhancement of adaptive immune response [BP], cysteine biosynthetic process via cystathionine [BP], cystathionine beta-synthase activity [MF], cysteine biosynthetic process from serine [BP]
CG_imr90r1_promoter_n_PM_16_18_9			2	1.0	9.51E-05	TGFB1	defense response to fungus, incompatible interaction [BP], negative regulation of hyaluronan biosynthetic process [BP], positive regulation of NAD+ ADP-ribosyltransferase activity [BP]
CG_imr90r1_promoter_n_PM_14_51_5			2	1.0	2.45E-05	NUDT5, ADCY3, HYAL2	hyaluronoglucuronidase activity [MF], negative regulation of fibroblast migration [BP], transformation of host cell by virus [BP], D-ribose catabolic process [BP], cellular response to fibroblast growth factor stimulus [BP], viral entry into host cell via membrane fusion with the plasma membrane [BP], ADP-sugar diphosphatase activity [MF], water transport [BP], receptor signaling protein tyrosine kinase inhibitor activity [MF]
CG_imr90r1_promoter_n_PM_16_23_20			1	0.5	6.24E-05	KLHL12, NTF4, SLC25A17	FMN transmembrane transporter activity [MF], FAD transmembrane transporter activity [MF], NAD transporter activity [MF], sensory organ boundary specification [BP], ER to Golgi transport vesicle [CC], FAD transmembrane transport [BP]
CG_imr90r1_promoter_n_PM_12_116_6			2	1.0	5.02E-05	HAL, PAWR	histidine ammonia-lyase activity [MF], positive regulation of amyloid precursor protein biosynthetic process [BP]
CG_imr90r1_promoter_n_PM_16_16_11			2	1.0	1.60E-04	NLRP12, GIP	negative regulation of Toll signaling pathway [BP], regulation of interleukin-18 biosynthetic process [BP], positive regulation of glucagon secretion [BP]
CG_imr90r1_promoter_n_PM_12_90_6			2	1.0	3.99E-04	KRT32, KRT35, KRT34, KRT36, HPS4, KRT31	structural molecule activity [MF], positive regulation of eye pigmentation [BP], intermediate filament [CC], epidermis development [BP]
CG_imr90r1_promoter_n_PM_12_82_4			1	0.5	5.31E-05	GSR, CRYZL1	glutathione-disulfide reductase activity [MF], NADP binding [MF]
CG_imr90r1_promoter_n_PM_12_92_4			2	1.0	1.03E-05	KIF13A	cargo loading into vesicle [BP]
CG_imr90r1_promoter_n_PM_12_13_4			1	0.5	3.53E-05	ECHDC1, ANK1	methylmalonyl-CoA decarboxylase activity [MF], maintenance of epithelial cell apical/basal polarity [BP], sarcoplasmic reticulum [CC]
CG_imr90r1_promoter_n_PM_12_20_4			1	0.5	4.38E-05	UXS1	UDP-D-xylose biosynthetic process [BP], UDP-glucuronate decarboxylase activity [MF]
CG_imr90r1_promoter_n_PM_16_36_27			2	1.0	7.83E-05	THY1, FIZ1, PAWR, STRADA, ADAM10	negative regulation of T cell receptor signaling pathway [BP], kinase binding [MF], protein kinase binding [MF]
CG_imr90r1_promoter_n_PM_12_153_10			2	1.0	5.72E-05	SDC4, ITGA5, MAP2K2	cell-substrate junction assembly [BP], peptidyl-serine autophosphorylation [BP], focal adhesion [CC]
CG_imr90r1_promoter_n_PM_20_15_23			2	1.0	3.46E-05	LEO1, MEN1, GRSF1	negative regulation of organ growth [BP], mRNA polyadenylation [BP]
CG_imr90r1_promoter_n_PM_12_28_4			1	0.5	1.28E-04	UNC93B1	toll-like receptor 9 signaling pathway [BP], toll-like receptor 7 signaling pathway [BP], early phagosome [CC]
CG_imr90r1_promoter_n_PM_14_10_6			1	0.5	3.59E-05	SLC38A7, GRPEL1	adenyl-nucleotide exchange factor activity [MF], L-leucine transmembrane transporter activity [MF], L-methionine transmembrane transporter activity [MF], L-asparagine transmembrane transporter activity [MF]
CG_imr90r1_promoter_n_PM_12_15_6			1	0.5	1.13E-05	SCIMP, CHMP1A	tetraspanin-enriched microdomain [CC], uropod membrane [CC], negative regulation of transcription by glucose [BP]
CG_imr90r1_promoter_n_PM_12_141_6			1	0.5	6.23E-05	AURKA	regulation of centrosome cycle [BP]
CG_imr90r1_promoter_n_PM_14_53_5			1	0.5	5.72E-05	MEX3D	mRNA localization resulting in posttranscriptional regulation of gene expression [BP]
CG_imr90r1_promoter_n_PM_12_30_7			2	1.0	7.30E-05	MEFV	negative regulation of macrophage inflammatory protein 1 alpha production [BP]
CG_imr90r1_promoter_n_PM_12_96_8			3	1.0	4.84E-05	E2F2, TRPT1	tRNA 2'-phosphotransferase activity [MF], core promoter binding [MF]
CG_imr90r1_promoter_n_PM_20_22_24			2	1.0	3.45E-05	NUP43, CENPK	mitotic cell cycle [BP]
CG_imr90r1_promoter_n_PM_12_57_7			2	1.0	2.68E-05	TP53, APOA1, RAB3A, CP	apolipoprotein A-I receptor binding [MF], chaperone binding [MF], copper ion binding [MF], negative regulation of interleukin-1 beta secretion [BP], maintenance of presynaptic active zone structure [BP], regulation of synaptic vesicle fusion to presynaptic membrane [BP], negative regulation of cell adhesion molecule production [BP], small GTPase mediated signal transduction [BP], sensory perception of touch [BP]
CG_imr90r1_promoter_n_PM_14_46_4			1	0.5	5.42E-05	LDHD	D-lactate dehydrogenase (cytochrome) activity [MF]
CG_imr90r1_promoter_n_PM_12_17_7			1	0.5	3.90E-05	COL11A1, USP6NL	retrograde transport, plasma membrane to Golgi [BP], collagen type XI [CC]
CG_imr90r1_promoter_n_PM_12_99_7			1	0.5	4.18E-05	NUFIP1, TACR1	substance P receptor activity [MF], perichromatin fibrils [CC]
CG_imr90r1_promoter_n_PM_12_60_11			2	1.0	7.55E-05	CLIP1	macropinosome [CC]
CG_imr90r1_promoter_n_PM_14_42_6			1	0.5	1.05E-04	GPR143, TONSL	FACT complex [CC], L-DOPA binding [MF], tyrosine binding [MF], L-DOPA receptor activity [MF]
CG_imr90r1_promoter_n_PM_12_53_5			2	0.5	1.09E-04	TNIP1	modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade [BP]
CG_imr90r1_promoter_n_PM_18_12_10			2	1.0	4.16E-05	ENG	endothelial microparticle [CC], cell migration involved in endocardial cushion formation [BP], galactose binding [MF], type I transforming growth factor beta receptor binding [MF], chronological cell aging [BP], detection of hypoxia [BP], transforming growth factor beta receptor homodimeric complex [CC], central nervous system vasculogenesis [BP], type II transforming growth factor beta receptor binding [MF]
CG_imr90r1_promoter_n_PM_14_9_8			2	1.0	6.12E-05	EIF2AK2	evasion or tolerance by virus of host immune response [BP]
CG_imr90r1_promoter_n_PM_12_151_11			2	1.0	6.99E-05	IL4I1, NRL, C3AR1	positive regulation of rhodopsin gene expression [BP], C3a anaphylatoxin receptor activity [MF], L-amino-acid oxidase activity [MF], complement component C3a receptor activity [MF]
CG_imr90r1_promoter_n_PM_12_87_5			2	1.0	2.34E-05	PABPC1, KIF5B, SPAG8, HOOK2	negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [BP], microtubule binding [MF]
CG_imr90r1_promoter_n_PM_18_1_74			2	1.0	6.08E-05	NUP62, FBP1, ENO1	dephosphorylation [BP], gluconeogenesis [BP], carbohydrate metabolic process [BP]
CG_imr90r1_promoter_n_PM_12_85_7			2	1.0	1.84E-05	RHOA, ITGB1	alpha9-beta1 integrin complex [CC], cleavage furrow [CC], alpha3-beta1 integrin complex [CC]
CG_imr90r1_promoter_n_PM_18_4_23			1	0.5	1.95E-05	GRIK5, MTNR1A	receptor clustering [BP], receptor complex [CC]
CG_imr90r1_promoter_n_PM_12_55_5			2	1.0	7.71E-05	POFUT2, LOXL2	epithelial to mesenchymal transition [BP], peptide-O-fucosyltransferase activity [MF]
CG_imr90r1_promoter_n_PM_14_6_11			2	1.0	3.90E-05	SLC11A2, DNASE1L1	DNA catabolic process [BP], vacuole [CC]
CG_imr90r1_promoter_n_PM_14_44_9			1	0.5	6.23E-05	CSGALNACT1, SCIMP	tetraspanin-enriched microdomain [CC], uropod membrane [CC], peptidoglycan glycosyltransferase activity [MF]
CG_imr90r1_promoter_n_PM_12_144_6			1	0.5	7.26E-05	NUFIP1, TFR2	transferrin receptor activity [MF], perichromatin fibrils [CC]
CG_imr90r1_promoter_n_PM_18_14_24			1	0.5	7.76E-05	MST1R, KIFC3, DDX39A, CHD5	macrophage colony-stimulating factor signaling pathway [BP], ATP-dependent helicase activity [MF], macrophage colony-stimulating factor receptor activity [MF], zonula adherens maintenance [BP], ATP binding [MF]
CG_imr90r1_promoter_n_PM_12_156_12			1	0.5	1.68E-04	COL7A1	collagen type VII [CC]
CG_imr90r1_promoter_n_PM_12_135_4			1	0.5	1.12E-04	XBP1	serotonin secretion, neurotransmission [BP], epithelial cell maturation involved in salivary gland development [BP]
CG_imr90r1_promoter_n_PM_12_83_6			1	0.5	1.81E-04	CYP7A1, UBE2D3, LIF	cholesterol 7-alpha-monooxygenase activity [MF], positive regulation of histone H3-K27 acetylation [BP], negative regulation of type I interferon production [BP], positive regulation of protein localization to nucleus [BP], RNA polymerase II transcription factor recruiting transcription factor activity [MF]
CG_imr90r1_promoter_n_PM_14_1_10			2	1.0	2.38E-05	NOA1, NOS2	regulation of cellular respiration [BP]
CG_imr90r1_promoter_n_PM_12_21_4			1	0.5	4.81E-05	FMN1, CDC42EP5, NGF	nerve growth factor receptor binding [MF], positive regulation of actin filament polymerization [BP], positive regulation of nerve growth factor receptor signaling pathway [BP], positive regulation of actin nucleation [BP]
CG_imr90r1_promoter_n_PM_18_30_14			2	1.0	3.70E-05	DPM1, SLBP	DNA replication involved in S phase [BP], dolichol-phosphate-mannose synthase complex [CC], histone pre-mRNA stem-loop binding [MF]
CG_imr90r1_promoter_n_PM_12_23_5			1	0.5	3.28E-05	PRODH, DLGAP5, IL12RB1	interleukin-23 receptor complex [CC], interleukin-23-mediated signaling pathway [BP], interleukin-23 binding [MF], mitotic chromosome movement towards spindle pole [BP], interleukin-12 receptor complex [CC], interleukin-12 receptor activity [MF], proline dehydrogenase activity [MF], interleukin-23 receptor activity [MF]
CG_imr90r1_promoter_n_PM_14_20_4			3	1.0	4.75E-05	NEDD4, PPP1R3C, TREH	trehalose metabolic process [BP], alpha,alpha-trehalase activity [MF], protein serine/threonine phosphatase activity [MF], negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [BP], transmission of virus [BP], protein K63-linked ubiquitination [BP], trehalose catabolic process [BP], development involved in symbiotic interaction [BP]
CG_imr90r1_promoter_n_PM_16_7_12			2	1.0	2.94E-05	MSRB1	methionine-R-sulfoxide reductase activity [MF]
CG_imr90r1_promoter_n_PM_12_51_9			2	1.0	3.18E-04	TACSTD2, RPL3L, RPS13	translational termination [BP], negative regulation of ruffle assembly [BP]
CG_imr90r1_promoter_n_PM_12_118_5			1	0.5	2.10E-04	NPTX1	axonogenesis involved in innervation [BP]
CG_imr90r1_promoter_n_PM_12_75_12			2	1.0	3.19E-04	STRA6, SALL1, ALDH4A1, HEY1, IL12B	interleukin-12 alpha subunit binding [MF], adrenal gland development [BP], embryonic digestive tract development [BP], pulmonary valve morphogenesis [BP], ventricular septum development [BP], 1-pyrroline-5-carboxylate dehydrogenase activity [MF]
CG_imr90r1_promoter_n_PM_18_6_19			2	1.0	7.26E-05	RC3H1	regulation of germinal center formation [BP]
CG_imr90r1_promoter_n_PM_12_19_4			2	1.0	5.94E-06	TBCC	post-chaperonin tubulin folding pathway [BP]
CG_imr90r1_promoter_n_PM_12_10_6			2	1.0	1.23E-04	SHH	CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [BP], intein-mediated protein splicing [BP], right lung development [BP], mesenchymal smoothened signaling pathway involved in prostate gland development [BP], regulation of mesenchymal cell proliferation involved in prostate gland development [BP], positive regulation of skeletal muscle cell proliferation [BP], negative regulation of kidney smooth muscle cell differentiation [BP], positive regulation of epithelial cell proliferation involved in prostate gland development [BP], primary prostatic bud elongation [BP], negative regulation of ureter smooth muscle cell differentiation [BP], epithelial-mesenchymal signaling involved in prostate gland development [BP], positive regulation of kidney smooth muscle cell differentiation [BP], positive regulation of ureter smooth muscle cell differentiation [BP], positive regulation of sclerotome development [BP], multicellular structure septum development [BP]
CG_imr90r1_promoter_n_PM_16_3_20			1	0.5	1.74E-05	TMEM123	oncosis [BP]
CG_imr90r1_promoter_n_PM_12_80_4			1	0.5	4.77E-05	RAB17	immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [BP]
CG_imr90r1_promoter_n_PM_14_4_10			1	0.5	9.51E-05	GDE1, BAZ2A	heterochromatin assembly involved in chromatin silencing [BP], chromatin remodeling [BP], glycerophosphoinositol glycerophosphodiesterase activity [MF]
CG_imr90r1_promoter_n_PM_18_26_8			2	1.0	7.86E-05	OCSTAMP	positive regulation of osteoclast proliferation [BP]
CG_imr90r1_promoter_n_PM_14_29_5			1	0.5	1.82E-05	SEC23A, PICALM, CLTB, PPP4R1	clathrin coat of coated pit [CC], clathrin heavy chain binding [MF], clathrin coat [CC], vesicle-mediated transport [BP], protein phosphatase type 4 regulator activity [MF], coated pit [CC]
CG_imr90r1_promoter_n_PM_12_65_9			2	1.0	2.33E-05	LCT, GALK1, AMACR	alpha-methylacyl-CoA racemase activity [MF], lactase activity [MF], glycosylceramidase activity [MF], galactokinase activity [MF]
CG_imr90r1_promoter_n_PM_12_157_5			1	0.5	1.03E-05	PEX6, HSPD1	ATPase activity [MF]
CG_imr90r1_promoter_n_PM_12_93_4			2	1.0	1.67E-04	APMAP, FOXP1, MNX1, PTK2, CPOX	motor neuron axon guidance [BP], strictosidine synthase activity [MF], netrin-activated signaling pathway [BP], ventral spinal cord development [BP], response to arsenic-containing substance [BP]
CG_imr90r1_promoter_n_PM_14_50_6			2	1.0	1.99E-04	ZNF121, ZNF670, EIF2AK1, ZNF841, LTN1, ZNF585A, ZNF83, ZNF432, ZNF417, ZNF415, B3GNT1	negative regulation of hemoglobin biosynthetic process [BP], zinc ion binding [MF], negative regulation of translational initiation by iron [BP], N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [MF], nucleic acid binding [MF]
CG_imr90r1_promoter_n_PM_12_27_7			1	0.5	1.58E-04	THOC1, NAA11, EQTN	inner acrosomal membrane [CC], peptide alpha-N-acetyltransferase activity [MF], intronless viral mRNA export from host nucleus [BP], outer acrosomal membrane [CC], acrosomal vesicle exocytosis [BP]
CG_imr90r1_promoter_n_PM_18_28_26			2	1.0	5.48E-05	TTN, ACTA1	skeletal muscle thin filament assembly [BP]
CG_imr90r1_promoter_n_PM_14_18_2			1	0.5	5.20E-05	BAZ1B	vitamin D receptor activator activity [MF], DNA replication-dependent nucleosome disassembly [BP]
CG_imr90r1_promoter_n_PM_16_22_5			2	1.0	2.73E-05	KLF16, TGFBR3	transforming growth factor beta receptor complex assembly [BP], response to luteinizing hormone stimulus [BP], transforming growth factor beta receptor activity, type III [MF], regulation of transcription from RNA polymerase II promoter [BP]
CG_imr90r1_promoter_n_PM_12_97_5			1	0.5	4.40E-05	OCA2, ACOX3	arsenite transport [BP], pristanoyl-CoA oxidase activity [MF], tyrosine transport [BP], arsenite transmembrane transporter activity [MF], L-tyrosine transmembrane transporter activity [MF]
CG_imr90r1_promoter_n_PM_18_27_11			1	0.5	2.91E-05	DCTPP1, C22orf28	RNA ligase (ATP) activity [MF], dCTP diphosphatase activity [MF], pyrimidine deoxyribonucleotide binding [MF]
CG_imr90r1_promoter_n_PM_20_2_21			2	1.0	1.04E-04	HSD17B10	cholate 7-alpha-dehydrogenase activity [MF], 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [MF]
CG_imr90r1_promoter_n_PM_20_19_38			2	1.0	5.38E-05	ABHD11, RAB6A, RGPD3, DCP1A, TRIP11, CMBL	protein localization to Golgi apparatus [BP], hydrolase activity [MF], protein targeting to Golgi [BP]
CG_imr90r1_promoter_n_PM_16_12_18			2	1.0	3.21E-05	CARD8, NIN, DIMT1	NACHT domain binding [MF], 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [MF], centrosome-templated microtubule nucleation [BP], NLRP3 inflammasome complex [CC]
CG_imr90r1_promoter_n_PM_18_29_16			1	0.5	3.48E-05	ZNF384, LRP6, CSNK1A1, PYGO1, FZD5	Wnt receptor signaling pathway involved in dorsal/ventral axis specification [BP], nucleocytoplasmic transport [BP], Wnt receptor signaling pathway [BP]
CG_imr90r1_promoter_n_PM_12_91_5			1	0.5	6.43E-05	ASPM	negative regulation of asymmetric cell division [BP]
CG_imr90r1_promoter_n_PM_12_61_3			1	0.5	1.10E-05	GNPNAT1, GBX2	glucosamine 6-phosphate N-acetyltransferase activity [MF], monosaccharide binding [MF], rhombomere 2 development [BP]
CG_imr90r1_promoter_n_PM_12_124_11			1	0.5	1.87E-04	SIN3A	response to methylglyoxal [BP], negative regulation of histone H3-K27 acetylation [BP]
CG_imr90r1_promoter_n_PM_12_127_11			1	0.5	6.65E-05	ATXN3, L1CAM, LONP1	misfolded or incompletely synthesized protein catabolic process [BP], positive regulation of calcium-mediated signaling [BP]
CG_imr90r1_promoter_n_PM_20_5_39			2	1.0	7.66E-05	AKT1S1, MTOR, COG5, COG7	negative regulation of cell size [BP], Golgi transport complex [CC], TORC1 complex [CC]
CG_imr90r1_promoter_n_PM_12_133_4			1	0.5	2.46E-05	GLUL	dynein light chain binding [MF]
CG_imr90r1_promoter_n_PM_12_145_4			1	0.5	2.27E-04	TNNC1	regulation of muscle filament sliding speed [BP]
CG_imr90r1_promoter_n_PM_12_147_3			2	1.0	1.27E-04	TKT	glyceraldehyde-3-phosphate biosynthetic process [BP], transketolase activity [MF], xylulose biosynthetic process [BP]
CG_imr90r1_promoter_n_PM_14_11_12			2	1.0	5.67E-05	EPOR	erythropoietin receptor activity [MF], erythropoietin-mediated signaling pathway [BP]
CG_imr90r1_promoter_n_PM_12_35_8			2	1.0	5.01E-05	MYO5A, GPR179	protein localization to plasma membrane [BP]
CG_imr90r1_promoter_n_PM_12_42_4			1	0.5	8.65E-05	SLC22A6, CTSH	renal tubular secretion [BP], HLA-A specific activating MHC class I receptor activity [MF]
CG_imr90r1_promoter_n_PM_16_35_34			1	0.5	2.51E-05	APOH, BTK, TGFB1	defense response to fungus, incompatible interaction [BP], eukaryotic cell surface binding [MF], negative regulation of hyaluronan biosynthetic process [BP], regulation of B cell cytokine production [BP], positive regulation of NAD+ ADP-ribosyltransferase activity [BP], negative regulation of endothelial cell migration [BP]
CG_imr90r1_promoter_n_PM_12_112_6			1	0.5	6.03E-05	PYCARD, DFFA, SLC17A3, PLA2G6	positive regulation of release of cytochrome c from mitochondria [BP], deoxyribonuclease activity [MF], regulation of anion transport [BP]
CG_imr90r1_promoter_n_PM_18_10_12			1	0.5	2.59E-05	TNIP2	toll-like receptor 9 signaling pathway [BP]
CG_imr90r1_promoter_n_PM_12_131_8			1	0.5	1.13E-04	HIBCH	3-hydroxyisobutyryl-CoA hydrolase activity [MF]
CG_imr90r1_promoter_n_PM_18_3_83			2	1.0	5.87E-05	HYAL2, GSK3B, INSR, PRKACA, PRKAR1B, ADCY3	energy reserve metabolic process [BP], activation of protein kinase A activity [BP], transformation of host cell by virus [BP], cellular response to fibroblast growth factor stimulus [BP], cellular response to glucagon stimulus [BP], activation of phospholipase C activity [BP], positive regulation of protein export from nucleus [BP], water transport [BP], cAMP-dependent protein kinase complex [CC]
CG_imr90r1_promoter_n_PM_12_121_9			2	0.5	2.05E-05	APBA1, SFRP5, TPMT	thiopurine S-methyltransferase activity [MF], synaptic vesicle [CC], negative regulation of Wnt receptor signaling pathway involved in digestive tract morphogenesis [BP], PDZ domain binding [MF]
CG_imr90r1_promoter_n_PM_12_39_3			2	1.0	5.97E-05	FBXW5, GLMN	hepatocyte growth factor receptor binding [MF], ubiquitin-protein ligase inhibitor activity [MF], cullin-RING ubiquitin ligase complex [CC], Cul4-RING ubiquitin ligase complex [CC]
CG_imr90r1_promoter_n_PM_12_37_4			1	0.5	6.97E-05	TPPP3, ANGPT2	negative regulation of positive chemotaxis [BP], microtubule bundle formation [BP]
CG_imr90r1_promoter_n_PM_16_1_7			2	1.0	5.14E-05	ATP5B	mitochondrial proton-transporting ATP synthase, catalytic core [CC]
CG_imr90r1_promoter_n_PM_12_1_5			1	0.5	3.09E-04	PNKP, TXNDC12	polynucleotide 3'-phosphatase activity [MF], nucleotide phosphorylation [BP], ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [MF], protein-disulfide reductase (glutathione) activity [MF]
CG_imr90r1_promoter_n_PM_12_110_5			2	1.0	7.06E-05	FOXD4, FOXD4L6, MTERF, TSHZ3	ureteric bud development [BP], iridophore differentiation [BP], axon extension involved in axon guidance [BP], dichotomous subdivision of terminal units involved in ureteric bud branching [BP], sympathetic nervous system development [BP], melanocyte differentiation [BP], positive regulation of BMP signaling pathway [BP], lateral line nerve glial cell development [BP], enteric nervous system development [BP], neural crest cell migration [BP], double-stranded DNA binding [MF], positive regulation of kidney development [BP]
CG_imr90r1_promoter_n_PM_12_24_7			1	0.5	6.64E-05	TMED5	endoplasmic reticulum exit site [CC]
CG_imr90r1_promoter_n_PM_12_149_6			1	0.5	2.35E-05	CARD8, POU5F1, BBC3	negative regulation of gene silencing by miRNA [BP], positive regulation of cysteine-type endopeptidase activity [BP], activation of cysteine-type endopeptidase activity involved in apoptotic process [BP], positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [BP]
CG_imr90r1_promoter_n_PM_12_73_6			1	0.5	7.04E-06	SRM, PPP4R1	spermidine synthase activity [MF], protein phosphatase type 4 regulator activity [MF]
CG_imr90r1_promoter_n_PM_14_34_17			3	1.0	6.97E-05	SLC30A1, SLC39A1	zinc ion transmembrane transporter activity [MF], zinc ion transmembrane transport [BP]
CG_imr90r1_promoter_n_PM_14_8_4			2	1.0	1.52E-04	ERCC2	SSL2-core TFIIH complex [CC]
CG_imr90r1_promoter_n_PM_14_49_8			1	0.5	1.50E-05	OTUD7B	protein K11-linked deubiquitination [BP]
CG_imr90r1_promoter_n_PM_16_32_11			2	1.0	2.47E-05	MAP4K1, ICMT, SLC25A17	protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [MF], FMN transmembrane transporter activity [MF], FAD transmembrane transporter activity [MF], NAD transporter activity [MF], MAP kinase kinase kinase kinase activity [MF], FAD transmembrane transport [BP]
CG_imr90r1_promoter_n_PM_18_25_23			2	1.0	2.64E-05	GSK3A, BAZ1B, POLD4, WAPAL, TK1, DNMT3A	S-adenosylhomocysteine metabolic process [BP], negative regulation of UDP-glucose catabolic process [BP], vitamin D receptor activator activity [MF], fetal process involved in parturition [BP], chromatin [CC], DNA replication [BP], DNA replication-dependent nucleosome disassembly [BP], DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [MF]
CG_imr90r1_promoter_n_PM_18_9_24			2	1.0	6.78E-05	PYGL, FKBP3, PPID	protein peptidyl-prolyl isomerization [BP], peptidyl-proline modification [BP], drug binding [MF]
CG_imr90r1_promoter_n_PM_12_100_7			1	0.5	7.13E-05	CYP7B1, OAT, KIAA0368, CALY	clathrin light chain binding [MF], ornithine-oxo-acid transaminase activity [MF], ER to Golgi transport vesicle [CC], 25-hydroxycholesterol 7alpha-hydroxylase activity [MF]
CG_imr90r1_promoter_n_PM_20_16_25			1	0.5	4.32E-05	AQP3, SOX15, MED1	regulation of keratinocyte differentiation [BP], positive regulation of G0 to G1 transition [BP], response to vitamin D [BP]
CG_imr90r1_promoter_n_PM_16_14_5			2	1.0	4.78E-05	IL5	interleukin-5 receptor binding [MF], positive regulation of eosinophil differentiation [BP]
CG_imr90r1_promoter_n_PM_12_137_8			1	0.5	6.04E-05	GLS2, GRM4	synaptic transmission [BP], neurotransmitter secretion [BP]
CG_imr90r1_promoter_n_PM_18_22_10			2	1.0	3.11E-05	STC2, HOMER1	regulation of store-operated calcium entry [BP]
CG_imr90r1_promoter_n_PM_14_43_10			1	0.5	4.12E-05	GABBR1	G-protein coupled receptor dimeric complex [CC]
CG_imr90r1_promoter_n_PM_20_3_34			1	0.5	3.97E-05	MYO1C, HSPA5, ALDH18A1	positive regulation of vascular endothelial growth factor signaling pathway [BP], glutamate 5-kinase activity [MF], glutamate-5-semialdehyde dehydrogenase activity [MF], regulation of protein folding in endoplasmic reticulum [BP], ornithine biosynthetic process [BP], myosin I complex [CC]
CG_imr90r1_promoter_n_PM_20_23_17			2	1.0	4.73E-05	FOXM1, DKK4, JUP	negative regulation of Wnt receptor signaling pathway [BP], embryo development [BP], negative regulation of Wnt receptor signaling pathway involved in heart development [BP]
CG_imr90r1_promoter_n_PM_12_106_7			1	0.5	4.81E-05	MTHFSD, GALNS	5-formyltetrahydrofolate cyclo-ligase activity [MF], N-acetylgalactosamine-4-sulfatase activity [MF], N-acetylgalactosamine-6-sulfatase activity [MF]
CG_imr90r1_promoter_n_PM_14_19_2			1	0.5	1.50E-05	L2HGDH	2-hydroxyglutarate dehydrogenase activity [MF]
CG_imr90r1_promoter_n_PM_12_68_5			1	0.5	1.05E-05	FOLH1, MMP20	regulation of enamel mineralization [BP], metallopeptidase activity [MF]
CG_imr90r1_promoter_n_PM_12_3_7			3	1.0	6.71E-05	PRF1	cytolytic granule [CC]
CG_imr90r1_promoter_n_PM_12_47_6			1	0.5	2.53E-04	ACOT12	acetyl-CoA hydrolase activity [MF]
CG_imr90r1_promoter_n_PM_16_10_3			1	0.5	1.23E-04	CHIT1	endochitinase activity [MF]
CG_imr90r1_promoter_n_PM_16_6_21			2	1.0	3.15E-05	CYP2A6, CYBA	smooth muscle hypertrophy [BP], coumarin 7-hydroxylase activity [MF], negative regulation of glomerular filtration by angiotensin [BP]
CG_imr90r1_promoter_n_PM_18_7_17			2	1.0	8.41E-05	LIMA1, TPM3, TGDS	negative regulation of actin filament depolymerization [BP], dTDP-glucose 4,6-dehydratase activity [MF], stress fiber [CC]
CG_imr90r1_promoter_n_PM_12_54_7			3	1.0	9.38E-05	INTS1, FLT3, ABCB11	bile acid-exporting ATPase activity [MF], sodium-exporting ATPase activity, phosphorylative mechanism [MF], canalicular bile acid transmembrane transporter activity [MF], pro-T cell differentiation [BP], U2 snRNA 3'-end processing [BP]
CG_imr90r1_promoter_n_PM_14_39_8			3	1.0	2.29E-05	YARS, ATXN2, HNRNPD	interleukin-8 receptor binding [MF], RNA binding [MF], tyrosyl-tRNA aminoacylation [BP], tyrosine-tRNA ligase activity [MF], negative regulation of receptor internalization [BP]
CG_imr90r1_promoter_n_PM_12_70_6			1	0.5	3.30E-05	APOD, ABCA1, BARD1, SLC16A1	apolipoprotein A-I receptor activity [MF], mevalonate transport [BP], negative regulation of lipoprotein lipid oxidation [BP], negative regulation of cytokine production involved in inflammatory response [BP], apolipoprotein A-I-mediated signaling pathway [BP], negative regulation of mRNA 3'-end processing [BP], cholesterol binding [MF], negative regulation of T cell migration [BP], mevalonate transmembrane transporter activity [MF]
CG_imr90r1_promoter_n_PM_12_26_5			1	0.5	3.65E-05	TMEM27, IL4I1	L-amino-acid oxidase activity [MF], peptidyl-dipeptidase activity [MF]
CG_imr90r1_promoter_n_PM_12_122_8			1	0.5	9.22E-05	HPSE	heparan sulfate proteoglycan catabolic process [BP], heparanase activity [MF]
CG_imr90r1_promoter_n_PM_12_111_3			1	0.5	1.48E-04	WNT7B	establishment or maintenance of polarity of embryonic epithelium [BP], outer medullary collecting duct development [BP]
CG_imr90r1_promoter_n_PM_16_33_9			1	0.5	1.86E-05	RAB3A, RHOG	clathrin-sculpted glutamate transport vesicle membrane [CC], GTPase activity [MF], regulation of synaptic vesicle fusion to presynaptic membrane [BP], clathrin-sculpted acetylcholine transport vesicle membrane [CC], sensory perception of touch [BP], maintenance of presynaptic active zone structure [BP]
CG_imr90r1_promoter_n_PM_14_36_5			1	0.5	5.72E-05	SNX8	early endosome to Golgi transport [BP]
CG_imr90r1_promoter_n_PM_12_161_6			1	0.5	2.07E-05	GSS	glutathione synthase activity [MF]
CG_imr90r1_promoter_n_PM_20_20_31			2	1.0	4.37E-05	AQP3, PRKAR1B, NANP	N-acylneuraminate-9-phosphatase activity [MF], water transport [BP]
CG_imr90r1_promoter_n_PM_12_108_7			2	1.0	6.41E-05	SPI1	negative regulation of histone H4 acetylation [BP]
CG_imr90r1_promoter_n_PM_12_130_3			1	0.5	5.82E-05	GSK3A, TMEM123, MMAB	negative regulation of UDP-glucose catabolic process [BP], oncosis [BP], cob(I)yrinic acid a,c-diamide adenosyltransferase activity [MF]
CG_imr90r1_promoter_n_PM_18_2_12			1	0.5	2.59E-05	TTLL1, PLOD3	procollagen glucosyltransferase activity [MF], tubulin-glutamic acid ligase activity [MF]
CG_imr90r1_promoter_n_PM_14_30_7			2	1.0	2.26E-05	NUP98, MLXIPL, IMPDH2, AKT1, MEX3D, SOD2	nitric oxide metabolic process [BP], nitric oxide biosynthetic process [BP], carbohydrate response element binding [MF], positive regulation of glucose metabolic process [BP], erythrophore differentiation [BP], apoptotic mitochondrial changes [BP], regulation of glucose transport [BP], mRNA localization resulting in posttranscriptional regulation of gene expression [BP], protein homotetramerization [BP], glycogen cell differentiation involved in embryonic placenta development [BP], vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [BP], positive regulation of lipid biosynthetic process [BP], positive regulation of nitric oxide biosynthetic process [BP], age-dependent response to reactive oxygen species [BP], glucose mediated signaling pathway [BP], release of cytochrome c from mitochondria [BP]